Derek DiRocco
InvestorPartner at RA Capital
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Experience
- RA Capital Management, L.P.Partnercurrent2020 — presentBoston, Massachusetts, United States
- RA Capital Management, L.P.Principal2017 — 2020Greater Boston Area
- RA Capital Management, L.P.Analyst2015 — 2017Boston, Massachusetts
- RA Capital Management, L.P.Associate2013 — 2015Boston, MA
- Mineralys Therapeutics, Inc.Directorcurrent2022 — present
- Bambusa TherapeuticsDirectorcurrent2025 — present
- EvommuneDirectorcurrent2024 — present
- Forward Therapeutics, Inc.Directorcurrent2023 — present
- Rivus PharmaceuticalsDirectorcurrent2022 — present
- Acrivon Therapeutics, Inc.Directorcurrent2021 — present
- Frontier MedicinesDirectorcurrent2021 — present
- Frontier MedicinesBoard Observer2019 — 2021
- Navigator Medicines, Inc.Board Observercurrent2024 — present
- Navigator Medicines, Inc.Director2024
- 89bioDirector2018 — 2025
- Interius BioTherapeuticsBoard Observer2021 — 2025
- Werewolf TherapeuticsDirector2021 — 2025
- IDRxDirector2024 — 2025
- Carmot Therapeutics, Inc.Board Observer2022 — 2023
- iTeos Therapeutics SADirector2020 — 2023
- VaxcyteBoard Observer2020
- Peloton TherapeuticsBoard Observer2019
- Harvard Medical SchoolPost-doctoral Research Fellow2009 — 2013
- UW MedicineGraduate Student - Pharmacology2005 — 2009
- Massachusetts General HospitalResearch Technician2002 — 2004
Skills & more
Molecular Biology18Neuroscience15Life Sciences9Genetics6Immunohistochemistry7Cell Biology8Microscopy4In Vivo3qPCR1Nephrology1Biotechnology7Pharmacology16
+12 more
Western BlottingConfocal MicroscopyMolecular CloningFluorescence MicroscopyLifesciencesCell CulturePCRLaboratoryTissue CultureDrug DiscoveryGenomicsScientific WritingFrom Derek's professional profile.
Deals · 7
Stipple BioBoard seat
via RA Capital · filed Apr 2026 · $100.2M raise
Rivus Pharmaceuticals, Inc.Board seat
via RA Capital · filed Jan 2025 · $57M raise
EvommuneBoard seat
via RA Capital · filed Jan 2025 · $115.5M raise
Mineralys TherapeuticsBoard seat
via RA Capital · filed Jun 2022 · $118M raise
Acrivon TherapeuticsBoard seat
via RA Capital · filed Nov 2021 · $100M raise
Day One BiopharmaceuticalsBoard seat
via RA Capital · filed Feb 2021 · $130M raise
Werewolf TherapeuticsBoard seat
via RA Capital · filed Jan 2021 · $72.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at RA Capital
Abigail Schmitz
Senior Associate, Corporate Development at RA Capital
Adam Kaye
Senior Managing Director and Partner, Structured Capital at RA Capital
Adrian Bot
Venture Partner at RA Capital
Albert Kim
Advisor at RA Capital
Alex Miller
Senior Associate, Venture at RA Capital
Alex Zhang
Vice President, Structured Capital at RA Capital
Alison Tisdale
Advisor at RA Capital
Alyssa Larson
Investor at RA Capital
Network4
Alyssa Larson
Investor at RA Capital
Andrew Levin
Partner at RA Capital
Anurag Kondapalli
Principal at RA Capital
Daniel Bahcheli
Investor at RA Capital
Investors connected to Derek in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Derek DiRocco?
- Partner at RA Capital
- Where does Derek DiRocco work?
- Derek DiRocco is Partner at RA Capital.
- What check size does Derek DiRocco write?
- Derek DiRocco typically writes checks of $100K – $5M.
- What boards does Derek DiRocco sit on?
- Derek DiRocco holds tracked board seats at Acrivon Therapeutics, Bambusa Therapeutics, Day One Biopharmaceuticals, Evommune, Mineralys Therapeutics, Rivus Pharmaceuticals, Inc., Stipple Bio, Werewolf Therapeutics.
- Where did Derek DiRocco go to school?
- Derek DiRocco studied at University of Washington - School of Medicine (PhD, Pharmacology); College of the Holy Cross (B.A., Biology).
Same school
Also attended University of Washington - School of Medicine12
Uri LopatinInvestor at Khosla VenturesDennis SchmulandInvestor at EPIC VENTURESDoug RossInvestor at DigitalDx VenturesDavid CohnInterim Chief Executive Officer and Chief Medical Officer at Oncology VenturesChing-Ping LinPartner & COO at Orbit StartupsJulien PhamFounder & Managing Partner at 3CC | Third Culture Capital
+ 6 more
Also attended College of the Holy Cross52
Nick WashburnSenior Managing Director, Intel Capital (North America)Sarah KimballInvestor at Spark CapitalLiz FoxProduct Marketing and Communications at In-Q-TelGabrielle BrigantiCommunications Associate at Deerfield Management CompanyJohn DelfinoPartner, General Counsel at TCVAdriana RocheHead of Talent at Uncork Capital
+ 46 more
Shared employers
Also worked at Frontier Medicines2
Also worked at Navigator Medicines, Inc.1
Also worked at Carmot Therapeutics, Inc.1
Also worked at Harvard Medical School215
Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux Capital
+ 209 more